Search Results - "Locklear, J.C." :: K.UTB vyhledávací portál

Methodology Using Pharmacy And Medical Claims Data To Evaluate Real-World Outcomes And Costs Of Ivf Treatment In The Us

by Corvino, F.A, Surinach, A, Locklear, J.C, Howe, A.M, Hayward, B, Mahony, M.C
Published in Value in health (01.05.2015)

Get full text

Journal Article

Loading…

A Pragmatic Literature Review Of Network Meta-Analyses Of Disease-Modifying Drugs In The Treatment Of Multiple Sclerosis

by Phillips, A.L, Beckerman, R, Smith, N.J, Locklear, J.C, Jiang, Y, Solon, C
Published in Value in health (01.05.2015)

Get full text

Journal Article

Loading…

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

by Phillips, A.L, Edwards, N.C, Locklear, J.C
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5–5.0)

by Phillips, A.L, Edwards, N.C, Locklear, J.C
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

Cost-Effectiveness Evaluation of Data from the Evidence (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study

by Phillips, A.L, Edwards, N.C, Locklear, J.C
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis

by Phillips, A.L, Kozma, C.M, Locklear, J.C
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database

by Phillips, A.L, Munsell, M.J, Menzin, J, Dangond, F, Locklear, J.C
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

PMH13 A Real-World Us Retrospective Database Analysis Evaluating Treatment Patterns, Health Care Resource Utilization and Costs in Patients with Bipolar Disorder Newly Treated with Immediate Release (IR) or Extended Release (XR) Quetiapine Fumarate

by Locklear, J.C, Alemayehu, B, Brody, R.S, Chavoshi, S, Tunceli, O, Kern, D, Earley, W.R
Published in Value in health (01.06.2012)

Get full text

Journal Article

Loading…

PMH71 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length and Costs of Hospitalisation of Patients with Schizophrenia or Bipolar Disorder

by Locklear, J.C, Wahlqvist, P, Gustafsson, U, Udd, M, Fajutrao, L, Eriksson, H
Published in Value in health (2011)

Get full text

Journal Article

Loading…

PMH72 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length of Hospitalisation of Patients with Acute Bipolar Mania

by Bonafede, M, Locklear, J.C, Wahlqvist, P, Fajutrao, L, Szamosi, J, Pan, K, Eriksson, H
Published in Value in health (2011)

Get full text

Journal Article

Loading…

PND56 - Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis

by Phillips, A.L., Kozma, C.M., Locklear, J.C.
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

PND41 - Cost-Effectiveness Evaluation of Data from the Evidence (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study

by Phillips, A.L., Edwards, N.C., Locklear, J.C.
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

PND45 - Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5–5.0)

by Phillips, A.L., Edwards, N.C., Locklear, J.C.
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

PND40 - An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

by Phillips, A.L., Edwards, N.C., Locklear, J.C.
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

PND13 - A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database

by Phillips, A.L., Munsell, M.J., Menzin, J., Dangond, F., Locklear, J.C.
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

PRM33 - Methodology Using Pharmacy And Medical Claims Data To Evaluate Real-World Outcomes And Costs Of Ivf Treatment In The Us

by Corvino, F.A., Surinach, A., Locklear, J.C., Howe, A.M., Hayward, B., Mahony, M.C.
Published in Value in health (01.05.2015)

Get full text

Journal Article

Loading…

PRM138 - A Pragmatic Literature Review Of Network Meta-Analyses Of Disease-Modifying Drugs In The Treatment Of Multiple Sclerosis

by Phillips, A.L., Beckerman, R., Smith, N.J., Locklear, J.C., Jiang, Y., Solon, C.
Published in Value in health (01.05.2015)

Get full text

Journal Article

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database